Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function

Open access
Whyte, Claire S, Bishop, Eileen T, Rückerl, Dominik, Gaspar-Pereira, Silvia, Barker, Robert N, Allen, Judith E, Rees, Andrew J, Wilson, Heather M · 2011 · Journal of Leukocyte Biology

Abstract

Macrophages become activated by their environment and develop polarized functions: classically activated (M1) macrophages eliminate pathogens but can cause tissue injury, whereas alternatively activated (M2) macrophages promote healing and repair. Mechanisms directing polarized activation, especially in vivo, are not understood completely, and here, we examined the role of SOCS proteins. M2 macrophages activated in vitro or elicited by implanting mice i.p. with the parasitic nematode Brugia malayi display a selective and IL-4-dependent up-regulation of SOCS1 but not SOCS3. Using siRNA-targeted knockdown in BMDM, we reveal that the enhanced SOCS1 is crucial for IL-4-induced M2 characteristics, including a high arginase I:iNOS activity ratio, suppression of T cell proliferation, attenuated responses to IFN-γ/LPS, and curtailed SOCS3 expression. Importantly, SOCS1 was essential in sustaining the enhanced PI3K activity that drives M2 activation, defining a new regulatory mechanism by which SOCS1 controls M2 polarization. By contrast, for M1 macrophages, SOCS1 was not only an important regulator of proinflammatory mediators (IL-6, IL-12, MHC class II, NO), but critically, for M1, we show that SOCS1 also restricted IL-10 secretion and arginase I activity, which otherwise would limit the efficiency of M1 macrophage proinflammatory responses. Together, our results uncover SOCS1, not only as a feedback inhibitor of inflammation but also as a critical molecular switch that tunes key signaling pathways to effectively program different sides of the macrophage balance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1189/jlb.1110644

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 34

  1. Wilson, 2010, Macrophages heterogeneity in atherosclerosis—implications for therapy, J. Cell. Mol. Med., 14, 2055, 10.1111/j.1582-4934.2010.01121.x · DOI
  2. Vernon, 2010, Macrophages and renal fibrosis, Semin. Nephrol., 30, 302, 10.1016/j.semnephrol.2010.03.004 · DOI
  3. Erwig, 2000, Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines, Am. J. Pathol., 156, 295, 10.1016/S0002-9440(10)64730-X · DOI
  4. Dalpke, 2008, Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins, Immunobiology, 213, 225, 10.1016/j.imbio.2007.10.008 · DOI · Paper page
  5. Tang, 2005, The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE–/–mice, Am. J. Pathol., 167, 901, 10.1016/S0002-9440(10)62061-5 · DOI
  6. Wong, 2006, SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis, J. Clin. Invest., 116, 1571, 10.1172/JCI25660 · DOI · Paper page
  7. Liu, 2008, Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo, J. Immunol., 180, 6270, 10.4049/jimmunol.180.9.6270 · DOI · Paper page
  8. Marine, 1999, SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality, Cell, 98, 609, 10.1016/S0092-8674(00)80048-3 · DOI · Paper page
  9. Starr, 1998, Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1, Proc. Natl. Acad. Sci. USA, 95, 14395, 10.1073/pnas.95.24.14395 · DOI · Paper page
  10. Brysha, 2001, Suppressor of cytokine signaling-1 attenuates the duration of interferon-γ signal transduction in vitro and in vivo, J. Biol. Chem., 276, 086
  11. O'Connor, 2007, Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3, J. Immunol., 178, 6886, 10.4049/jimmunol.178.11.6886 · DOI
  12. Zhou, 2007, Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme, Clin. Cancer Res., 13, 2344, 10.1158/1078-0432.CCR-06-2303 · DOI
  13. Hanada, 2005, Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene, J. Immunol., 174, 4325, 10.4049/jimmunol.174.7.4325 · DOI
  14. Baetz, 2004, Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells, J. Biol. Chem., 279, 54708, 10.1074/jbc.M410992200 · DOI · Paper page
  15. Mohrs, 2000, Interleukin-4 receptor α-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection, Infect. Immun., 68, 1773, 10.1128/IAI.68.4.1773-1780.2000 · DOI
  16. Loke, 2000, Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact, Eur. J. Immunol., 30, 2669, 10.1002/1521-4141(200009)30:9<2669::AID-IMMU2669>3.0.CO;2-1 · DOI · Paper page
  17. Wilson, 2002, Bone marrow derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis, Mol. Ther., 6, 710, 10.1006/mthe.2002.0802 · DOI
  18. Nair, 2005, Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Yml and Fizzl by antigen-presenting cells, Infect. Immun., 73, 385, 10.1128/IAI.73.1.385-394.2005 · DOI · Paper page
  19. Yu, 2004, Cell proliferation and STAT6 pathway are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling, J. Immunol., 173, 737, 10.4049/jimmunol.173.2.737 · DOI
  20. Corraliza, 1994, Determination of arginase activity in macrophages: a micromethod, J. Immunol. Methods, 174, 231, 10.1016/0022-1759(94)90027-2 · DOI · Paper page
  21. Dimitriou, 2008, Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins, Immunol. Rev., 224, 265, 10.1111/j.1600-065X.2008.00659.x · DOI · Paper page
  22. Dickensheets, 2007, Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling, Genes Immun., 8, 21, 10.1038/sj.gene.6364352 · DOI
  23. MacKinnon, 2008, Regulation of alternative macrophage activaton by galectin-3, J. Immunol., 180, 2650, 10.4049/jimmunol.180.4.2650 · DOI · Paper page
  24. Rauh, 2005, SHIP represses the generaton of alternatively activated macrophages, Immunity, 23, 361, 10.1016/j.immuni.2005.09.003 · DOI · Paper page
  25. Nakagawa, 2002, SOCS-1 participates in negative regulation of LPS responses, Immunity, 17, 677, 10.1016/S1074-7613(02)00449-1 · DOI · Paper page
  26. Gingras, 2004, Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of Toll-like receptor signaling, J. Biol. Chem., 279, 54702, 10.1074/jbc.M411043200 · DOI
  27. Prěle, 2008, SOCS1 regulates the IFN but not NFκB pathway in TLR-stimulated human monocytes and macrophages, J. Immunol., 181, 8018, 10.4049/jimmunol.181.11.8018 · DOI
  28. Babu, 2009, Alternatively activated and immunoregulatory monocytes in human filarial infections, J. Infect. Dis., 199, 1827, 10.1086/599090 · DOI
  29. Bystrom, 2008, Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP, Blood, 112, 4117, 10.1182/blood-2007-12-129767 · DOI · Paper page
  30. Fujimoto, 2002, A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo, Int. Immunol., 14, 1343, 10.1093/intimm/dxf094 · DOI
  31. Egwuagu, 2002, Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance, J. Immunol., 168, 3181, 10.4049/jimmunol.168.7.3181 · DOI · Paper page
  32. Hesse, 2001, Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism, J. Immunol., 167, 6533, 10.4049/jimmunol.167.11.6533 · DOI · Paper page
  33. Wilson, 2005, Inhibition of macrophage nuclear factor-κ B (NF-κB) leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo, Am. J. Pathol., 167, 27, 10.1016/S0002-9440(10)62950-1 · DOI
  34. Shen, 2004, Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity, Nat. Biotechnol., 22, 1546, 10.1038/nbt1035 · DOI · Paper page

Cited by

See all 215

Metadata

Authors
Whyte, C. S., Bishop, E. T., Rückerl, D., Gaspar-Pereira, S., Barker, R. N., Allen, J. E., Rees, A. J., & Wilson, H. M.
Venue
Journal of Leukocyte Biology
Published
2011-05-31
Volume
90
Issue
5
Pages
845-854
ISSN
  • 0741-5400 (ISSN-L)
  • 1938-3673
OpenAlex
W2124881273
Cited by
215
References
16
FWCI
7.73
Type
journal article
Language
en
Open access
bronze
Funders
  • Medical Research Council (74804, 78896)
  • NHS Grampian Endowments Research Trust (09/02)
  • Cunningham Trust (ACC/KWF/CT08/03)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. https://app.cochat.ai/papers/10.1189/jlb.1110644
The paper
Whyte, C. S., Bishop, E. T., Rückerl, D., Gaspar-Pereira, S., Barker, R. N., Allen, J. E., Rees, A. J., & Wilson, H. M. (2011). Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. Journal of Leukocyte Biology. https://doi.org/10.1189/jlb.1110644

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.